SMS PHARMACEUTICALS LTD. - 532815 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for TVT Infracon LLP SMS PHARMACEUTICALS LTD. - 532815 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
Transcript of the Conference Call held on 26th May, 2023. SMS PHARMACEUTICALS LTD. - 532815 - Compliances-Reg.24(A)-Annual Secretarial Compliance
Annual Secretarial Compliance Report for the financial year 2022-2023 SMS PHARMACEUTICALS LTD. - 532815 - Compliances-Reg.24(A)-Annual Secretarial Compliance
Annual Secretarial Compliance Report for the financial year 2022-23 SMS PHARMACEUTICALS LTD. - 532815 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
Audio recording of Analysts/Investors Conference Call SMS PHARMACEUTICALS LTD. - 532815 - Announcement under Regulation 30 (LODR)-Investor Presentation
Investor Presentation SMS PHARMACEUTICALS LTD. - 532815 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Press release on Financial Results SMS PHARMACEUTICALS LTD. - 532815 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Newspaper cuttings of published financial results SMS PHARMACEUTICALS LTD. - 532815 - Disclosure Of Related Party Transactions For The Half Year Ended 31St March, 2023
Disclosure of Related Party Transactions for the half year ended 31st March, 2023
